Global Monoclonal Antibody Medicine Industry

Global Monoclonal Antibody Medicine Industry Research & Trends Analysis Report

Global Monoclonal Antibody Medicine Industry

Global Monoclonal Antibody Medicine Industry Research & Trends Analysis Report


The Monoclonal Antibody Medicine study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to A Latest intelligence report published by Market IntelliX, the global market for Monoclonal Antibody Medicine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Monoclonal Antibody Medicine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Monoclonal Antibody Medicine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Biologics segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Cancer has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Monoclonal Antibody Medicine include Roche, Amgen, AbbVie, Sanofi, Johnson & Johnson, Pfizer, Eli Lilly, Novartis and Merck, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.

This report aims to provide a comprehensive study of the global market for Monoclonal Antibody Medicine. Report Highlights:

(1) Global Monoclonal Antibody Medicine market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Monoclonal Antibody Medicine market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Monoclonal Antibody Medicine market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Monoclonal Antibody Medicine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Monoclonal Antibody Medicine segment by type and by application and regional segment by type and by application.

(6) Monoclonal Antibody Medicine industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Biologics

Biosimilars

Market segment by application, can be divided into

Cancer

Autoimmune Disease

Other

Market segment by players, this report covers

Roche

Amgen

AbbVie

Sanofi

Johnson & Johnson

Pfizer

Eli Lilly

Novartis

Merck

Biogen

Celltrion

Sobi

3SBIO

Innovent Biologics

1 Market Overview

1.1 Product Overview and Scope of Monoclonal Antibody Medicine

1.2 Global Monoclonal Antibody Medicine Market Size and Forecast

1.3 China Monoclonal Antibody Medicine Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Monoclonal Antibody Medicine Share in Global Market, 2018-2029

1.4.2 Monoclonal Antibody Medicine Market Size: China VS Global, 2018-2029

1.5 Monoclonal Antibody Medicine Market Dynamics

1.5.1 Monoclonal Antibody Medicine Market Drivers

1.5.2 Monoclonal Antibody Medicine Market Restraints

1.5.3 Monoclonal Antibody Medicine Industry Trends

1.5.4 Monoclonal Antibody Medicine Industry Policy

2 Global Competitive Situation by Company

2.1 Global Monoclonal Antibody Medicine Revenue by Company (2018-2023)

2.2 Global Monoclonal Antibody Medicine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Monoclonal Antibody Medicine Concentration Ratio

2.4 Global Monoclonal Antibody Medicine Mergers & Acquisitions, Expansion Plans

2.5 Global Monoclonal Antibody Medicine Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Monoclonal Antibody Medicine Revenue by Company (2018-2023)

3.2 China Monoclonal Antibody Medicine Monoclonal Antibody Medicine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Monoclonal Antibody Medicine, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Monoclonal Antibody Medicine Industry Chain

4.2 Monoclonal Antibody Medicine Upstream Analysis

4.3 Monoclonal Antibody Medicine Midstream Analysis

4.4 Monoclonal Antibody Medicine Downstream Analysis

5 Sights by Type

5.1 Monoclonal Antibody Medicine Classification

5.1.1 Biologics

5.1.2 Biosimilars

5.2 By Type, Global Monoclonal Antibody Medicine Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Monoclonal Antibody Medicine Revenue, 2018-2029

6 Sights by Application

6.1 Monoclonal Antibody Medicine Segment by Application

6.1.1 Cancer

6.1.2 Autoimmune Disease

6.1.3 Other

6.2 By Application, Global Monoclonal Antibody Medicine Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Monoclonal Antibody Medicine Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Monoclonal Antibody Medicine Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Monoclonal Antibody Medicine Market Size, 2018-2029

7.3 North America

7.3.1 North America Monoclonal Antibody Medicine Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Monoclonal Antibody Medicine Market Size Market Share

7.4 Europe

7.4.1 Europe Monoclonal Antibody Medicine Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Monoclonal Antibody Medicine Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Monoclonal Antibody Medicine Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Monoclonal Antibody Medicine Market Size Market Share

7.6 South America

7.6.1 South America Monoclonal Antibody Medicine Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Monoclonal Antibody Medicine Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Monoclonal Antibody Medicine Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Monoclonal Antibody Medicine Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Monoclonal Antibody Medicine Market Size, 2018-2029

8.3.2 By Company, U.S. Monoclonal Antibody Medicine Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Monoclonal Antibody Medicine Market Size, 2018-2029

8.4.2 By Company, Europe Monoclonal Antibody Medicine Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Monoclonal Antibody Medicine Market Size, 2018-2029

8.5.2 By Company, China Monoclonal Antibody Medicine Revenue Market Share, 2018-2023

8.5.3 By Type, China Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Monoclonal Antibody Medicine Market Size, 2018-2029

8.6.2 By Company, Japan Monoclonal Antibody Medicine Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Monoclonal Antibody Medicine Market Size, 2018-2029

8.7.2 By Company, South Korea Monoclonal Antibody Medicine Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Monoclonal Antibody Medicine Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Monoclonal Antibody Medicine Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Monoclonal Antibody Medicine Market Size, 2018-2029

8.9.2 By Company, India Monoclonal Antibody Medicine Revenue Market Share, 2018-2023

8.9.3 By Type, India Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Monoclonal Antibody Medicine Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Monoclonal Antibody Medicine Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Monoclonal Antibody Medicine Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Roche

9.1.1 Roche Company Information, Head Office, Market Area and Industry Position

9.1.2 Roche Company Profile and Main Business

9.1.3 Roche Monoclonal Antibody Medicine Models, Specifications and Application

9.1.4 Roche Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.1.5 Roche Recent Developments

9.2 Amgen

9.2.1 Amgen Company Information, Head Office, Market Area and Industry Position

9.2.2 Amgen Company Profile and Main Business

9.2.3 Amgen Monoclonal Antibody Medicine Models, Specifications and Application

9.2.4 Amgen Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.2.5 Amgen Recent Developments

9.3 AbbVie

9.3.1 AbbVie Company Information, Head Office, Market Area and Industry Position

9.3.2 AbbVie Company Profile and Main Business

9.3.3 AbbVie Monoclonal Antibody Medicine Models, Specifications and Application

9.3.4 AbbVie Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.3.5 AbbVie Recent Developments

9.4 Sanofi

9.4.1 Sanofi Company Information, Head Office, Market Area and Industry Position

9.4.2 Sanofi Company Profile and Main Business

9.4.3 Sanofi Monoclonal Antibody Medicine Models, Specifications and Application

9.4.4 Sanofi Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.4.5 Sanofi Recent Developments

9.5 Johnson & Johnson

9.5.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position

9.5.2 Johnson & Johnson Company Profile and Main Business

9.5.3 Johnson & Johnson Monoclonal Antibody Medicine Models, Specifications and Application

9.5.4 Johnson & Johnson Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.5.5 Johnson & Johnson Recent Developments

9.6 Pfizer

9.6.1 Pfizer Company Information, Head Office, Market Area and Industry Position

9.6.2 Pfizer Company Profile and Main Business

9.6.3 Pfizer Monoclonal Antibody Medicine Models, Specifications and Application

9.6.4 Pfizer Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.6.5 Pfizer Recent Developments

9.7 Eli Lilly

9.7.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position

9.7.2 Eli Lilly Company Profile and Main Business

9.7.3 Eli Lilly Monoclonal Antibody Medicine Models, Specifications and Application

9.7.4 Eli Lilly Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.7.5 Eli Lilly Recent Developments

9.8 Novartis

9.8.1 Novartis Company Information, Head Office, Market Area and Industry Position

9.8.2 Novartis Company Profile and Main Business

9.8.3 Novartis Monoclonal Antibody Medicine Models, Specifications and Application

9.8.4 Novartis Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.8.5 Novartis Recent Developments

9.9 Merck

9.9.1 Merck Company Information, Head Office, Market Area and Industry Position

9.9.2 Merck Company Profile and Main Business

9.9.3 Merck Monoclonal Antibody Medicine Models, Specifications and Application

9.9.4 Merck Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.9.5 Merck Recent Developments

9.10 Biogen

9.10.1 Biogen Company Information, Head Office, Market Area and Industry Position

9.10.2 Biogen Company Profile and Main Business

9.10.3 Biogen Monoclonal Antibody Medicine Models, Specifications and Application

9.10.4 Biogen Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.10.5 Biogen Recent Developments

9.11 Celltrion

9.11.1 Celltrion Company Information, Head Office, Market Area and Industry Position

9.11.2 Celltrion Company Profile and Main Business

9.11.3 Celltrion Monoclonal Antibody Medicine Models, Specifications and Application

9.11.4 Celltrion Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.11.5 Celltrion Recent Developments

9.12 Sobi

9.12.1 Sobi Company Information, Head Office, Market Area and Industry Position

9.12.2 Sobi Company Profile and Main Business

9.12.3 Sobi Monoclonal Antibody Medicine Models, Specifications and Application

9.12.4 Sobi Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.12.5 Sobi Recent Developments

9.13 3SBIO

9.13.1 3SBIO Company Information, Head Office, Market Area and Industry Position

9.13.2 3SBIO Company Profile and Main Business

9.13.3 3SBIO Monoclonal Antibody Medicine Models, Specifications and Application

9.13.4 3SBIO Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.13.5 3SBIO Recent Developments

9.14 Innovent Biologics

9.14.1 Innovent Biologics Company Information, Head Office, Market Area and Industry Position

9.14.2 Innovent Biologics Company Profile and Main Business

9.14.3 Innovent Biologics Monoclonal Antibody Medicine Models, Specifications and Application

9.14.4 Innovent Biologics Monoclonal Antibody Medicine Revenue and Gross Margin, 2018-2023

9.14.5 Innovent Biologics Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Monoclonal Antibody Medicine Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Monoclonal Antibody Medicine Market trending toward high growth trajectories?
A dynamic process in the Monoclonal Antibody Medicine Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Pfizer, AstraZeneca, Regeneron, Genentech, Sanofi.
What is the Monoclonal Antibody Medicine Market really preparing for?
Companies in the Monoclonal Antibody Medicine Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
What important business segments are segregated by application types in the latest edition of the Monoclonal Antibody Medicine Market?
The key business segments in the Monoclonal Antibody Medicine Market are segregated by applications [Oncology, Immunology, Neurology, Infectious Diseases] and types [IgG, IgA, IgM, IgE].
What is the estimated size & growth rate of the Monoclonal Antibody Medicine Market?
In recent years, the Monoclonal Antibody Medicine Market has grown at an incredible rate. From 2025 to 2030, the market is expected to grow at a CAGR of yy%.
What does the future hold for the Monoclonal Antibody Medicine Market?
As the shift to value addition continues, companies in the Monoclonal Antibody Medicine Market face the dual challenge of improving interoperability to optimize performance and experience.
What is the CAGR at which the Monoclonal Antibody Medicine Market can expand?
During the forecast years, the Monoclonal Antibody Medicine Market can thrive with a robust CAGR.